NeurogesX Inc (OTC Pink - No Information:NGSX)

Data as of Oct 17
 +0.0022 / +40.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

NeurogesX, Inc. is a biopharmaceutical company, which is focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs. Its product Qutenza, a synthetic capsaicin-based dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. The company was formerly known as Advanced Analgesics, Inc. and changed its name to NeurogesX, Inc. in September 2000. NeurogesX was founded by Wendye R. Robbins on May 28, 1998 and is headquartered in San Mateo, CA.

Contact Information

NeurogesX, Inc.
999 Baker Street
San Mateo California 94404
P:(650) 358-3300
Investor Relations:



Individual stakeholders43.77%
Mutual fund holders2.18%
Other institutional0.00%

Top Executives

Stephen F. GhiglieriChief Operating Officer, CFO, Secretary & EVP
Stephen J. PeroutkaChief Medical Officer & Executive Vice President
Russell T. KawahataVice President-Pharmaceutical Science
Linda L. SchockDirector-Commercial Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.